Orphazyme A/S ADR (ORPH): Price and Financial Metrics
ORPH Price/Volume Stats
| Current price | $0.87 | 52-week high | $77.77 |
| Prev. close | $0.89 | 52-week low | $0.51 |
| Day low | $0.85 | Volume | 941,400 |
| Day high | $0.96 | Avg. volume | 1,371,185 |
| 50-day MA | $1.51 | Dividend yield | N/A |
| 200-day MA | $3.77 | Market Cap | 30.72M |
ORPH Stock Price Chart Interactive Chart >
Orphazyme A/S ADR (ORPH) Company Bio
Orphazyme A/S engages in development of treatment for patients living with life-threatening and debilitating rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Mørkeberg Hinsby, Marja Jäättela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.
ORPH Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -74.64% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -77.54% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...